Insider · CIK 0001861844
Arjun Goyal
director
Files at CNTA (Centessa Pharmaceuticals plc). First filing May 19, 2025, latest May 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$5.9M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | CNTAbuy Centessa Pharmaceuticals plc | $5.9M 462,585 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | CNTA Centessa Pharmaceuticals plc | AGrant or award Share Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 24, 2025 |
| May 15, 2025 | CNTA Centessa Pharmaceuticals plc | POpen-market purchase Ordinary Sharesindirect: See footnote | +44,939 | $12.24 | $550k | 44,939 | May 19, 2025 |
| May 16, 2025 | CNTA Centessa Pharmaceuticals plc | POpen-market purchase Ordinary Sharesindirect: See footnote | +417,646 | $12.73 | $5.3M | 462,585 | May 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.